FDA Investigator Djamila Harouaka

Djamila Harouaka has inspections in 9 countries as of 21 Sep 2023. Djamila Harouaka has collaborated with a combinined 4266 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
53
Last Inspection Date:
21 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
China, Japan, United States of America, Taiwan, France, Germany, Ireland, India, Canada
Co-Investigator(s):
A Williams, Adetutu M Gidado, Akbar J Zaidi, Alan P Kurtzberg, Ana Djurdjevic, Andrea A Branche, Andrew J Barrowcliff, Angela E Glenn, Anita Narula, PhD, Anita R Michael, Ann L Demarco, Anne L Aberdeen, Arsen Karapetyan, Aurora Miha Trifanov, Azza Talaat, Barbara A Gullick, Barbara Janine Breithaupt, Benjamin J Dastoli, Binh T Nguyen, Bowman, Brandon K Lawson, Brenda W Uratani, PhD, Brian D Rogers, Brian L Belz, Brooke K Higgins, Bryan L Mcguckin, Bryce A Hammer, Carl Lee, Caryn M Mcnab, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Cecilia H Kieu, Celena Ngo, Charisse K Green, Charles C Conn, III, Charles Cconn Lii, Charles M Edwards, Cheryl A Clausen, Chiaochun J Wang, Christina A Miller, Christopher M Jenner, Christopher M Reed, Christopher S Keating, Christopher T Middendorf, Ciara J Bajulai Austin, Claire M Minden, Claudia Mperez Kasmarski, Darren S Brown, David J Hafner, David M Beltran, David Y Hernandez, Davis, Dell S Moller, Denise M Digiulio, Diane L Raccasi, Dongping Dai, PhD, Douglas A Campbell, Dr. Gang Wang, PhD, Dr. Ralph M Bernstein, PhD, Edmund F Mrak, Jr, Edwin Martinez, Eileen A Liu, Elizabeth A Laudig, Elizabeth Ll Edwards, Emest F Bizjak, Emmanuel A Dimaano, Jr, Erica R Havely, Erica R Woody, Felix Maldonado, Francis A Guidry, Frank Wackes, Frederick M Lochner, Gam S Zamil, Greg K Keshishyan, Gwyn G Dickinson, Hala L Selby, Harperd, Harry J Brewer, Helen B Ricalde, Hugh M Mcclure, II, Ileana Barreta Pettit, Ivan E Reyes, Jacob W Reynolds, Jai P Singh, James D Planchon, James P Stallings, James S Cartwright, Jane L Chang, Jason F Chancey, Jean Blackstone Hill, Jeannie Pradyanata, Jeff M Uriarte, Jeffrey A Sincek, Jeffrey P Raimondi, Jennifer A Robinson, Jennifer M Gogley, Jesse A Vazquez, Joanne E King, Joey V Quitania, Jogy George, John A Daubenspeck, John A Gonzalez, John P Jorgensen, Jorge L Guadalupe, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Melendez, Joseph C Yen, Joshua P Wireman, Joshua S Hunt, Judy C Nepsa, Karen M Kondas, Karen Takahashi, Katherine E Jacobitz, Katherine Szestypalow, Kelley, Kelli Wilkinson, Kelvin X Sanders, Kevin D Kallander, Kevin Lee, Kham Phommachanh, Kristy A Zielny, Kristy E Zuroski, Lance A Finnical, Lata C Mathew, PhD, Laura A Munsterman, Lauren N Howard, Lauren N Smith, Laurimer Kuilan Torres, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Michael H Tollon, Leiyun Boone, PhD, Linda F Murphy, Linda Thai, Lloyd D Payne, Loretta J Jordan, Lorraine L Chavis, Louis G An, Lucas B Leake, Luis A Dasta, Maan S Abduldayem, Marcus F Yambot, Maria Joselopez Barragan, PhD, Marian E Ramirez, Mark C Saale, Mark E Parmon, Marsha L Mccauley, Matthew B Casale, Matthew C Watson, Matthew H Pitts, Matthew J Sienko, Maxwell Van Tassell, PhD, Michael A Charles, Michael A Taylor, Michael D Garcia, Michael L Casner, Michael P Sheehan, Michael R Goga, Mindy M Chou, Monica E Caphart, Mra Davism, Mra Mcculloughj, Nadeem I Chaudhry, Ngoc T Le, Nicholas L Hunt, Nicholas L Paulin, Noreen Muniz, Normica G Facey, Parul M Patel, Patricia P Wrona, Patrick C Klotzbuecher, Paul A Bonneau, Peng Zhou, Phillip M Pontikos, Pratik S Upadhyay, DDC, Qin Xu, Rachel C Stanton, Randall N Johnson, Rochelle A Rolnik, Rochelle L Cross, Roger F Zabinski, Rose Xu, Ruth Moore, PhD, S Lori Brown, PhD MPH, Saied A Asbagh, Samina S Khan, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah E Mcmullen, Scott T Ballard, Sena G Dissmeyer, Seneca D Toms, Sha'tina R Alridge, Sheila Alaghemand, Sixto M Mercado Rios, Stacie A Woods, State Agency, Steven Fong, MS, PhD, Steven M Weinman, Sundy Ven, Susan F Laska, MS, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Tajah L Blackburn, Tamala P Bogan, Tamala P Magee, Tamara L Ely, Tammy L Chavis, Tawny L Colling, Ted L Anderson, Thao T Kwan, Thomas E Friel, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy T Kapsala, Toyin B Oladimeji, Tracey L Harris, Truong Xuan Nguyen (Andy), Trushani T Desai, Tyra S Wisecup, Ucheabuchi C Chudi Nwankwor, Vilmary Negron Rodriguez, Vipulchandra N Dholakia, Virgilio F Pacio, CSO, Vlada Matusovsky, Walden H Lee, Wayne D Mcgrath, Wayne E Seifert, Wen Ning Chan (Sally), Wendy G Tan, PhD, William D Tingley, Zachary A Bogorad, Zachary L Miller, Zhao Wang, PhD, Zhigang Sun, PhD, Zi Qiang Gu

Djamila Harouaka's Documents

Publish Date Document Type Title
June, 2016 FDA 483 UNIVERSITY OF CALIFORNIA, LOS ANGELES - Form 483, 2016-06-02
June, 2019 FDA 483 Premier Pharmacy Labs Inc - Form 483, 2019-07-25
March, 2017 FDA 483 MedPark Pharmacy, LLC - Form 483, 2017-03-10
August, 2016 FDA 483 Apotex Inc. - Form 483, 2016-08-19
March, 2019 FDA 483 NIH Clinical Center Pharmacy Department - Form 483, 2019-03-06
December, 2015 FDA 483 Genlabs Corporation - Form 483, 2015-12-11
July, 2017 FDA 483 TITAN KOGYO ,LTD. - Form 483, 2017-07-07
January, 2018 FDA 483 GP Grenzach Produktions GmbH - Form 483, 2018-01-30
July, 2017 FDA 483 JO Cosmetics Co., Ltd. - Form 483, 2017-07-14
April, 2018 FDA 483 Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (FDF Site) - Form 483, 2018-04-03
September, 2017 FDA 483 Venator Germany GmbH - Form 483, 2017-09-22
October, 2018 FDA 483 Intact Pharmaceuticals LLC - Form 483, 2018-10-12
June, 2016 FDA 483 Option Care - Form 483, 2016-06-28
September, 2017 FDA 483 QUALI CONTROLE - Form 483, 2017-09-15
October, 2016 FDA 483 Hunter Holmes McGuire Veterans Affairs Medical Center Mammography - Form 483, 2016-10-25
December, 2017 FDA 483 Professional Arts Pharmacy - Form 483, 2017-12-12
March, 2016 FDA 483 Professional Arts Pharmacy - Form 483, 2016-03-23
April, 2017 FDA 483 Torrent Pharmaceuticals Limited - Form 483, 2017-04-28
August, 2015 EIR West-Ward Columbus Inc. - EIR, 2015-08-14
August, 2016 FDA 483 Groupe PARIMA Inc. - Form 483, 2016-08-12
December, 2016 FDA 483 Rentschler Biopharma SE - Form 483, 2016-12-06
February, 2016 FDA 483 Central Admixture Pharmacy Serv - Form 483, 2016-02-05
July, 2017 FDA 483 Daiwa Pharmaceutical Co., Ltd. - Form 483, 2017-07-21
June, 2016 FDA 483 Precision Pharmacy Center, LLC - Form 483, 2016-06-10
May, 2017 FDA 483 The Wellness Pharmacy - Form 483, 2017-05-16

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more